Construction and validation of nomogram model for predicting the risk of ventricular arrhythmia after emergency PCI in patients with acute myocardial infarction
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.This study developed a nomogram model to predict the risk of Malignant Ventricular Arrhythmia (MVA) after Percutaneous Coronary Intervention (PCI) in Acute Myocardial Infarction (AMI) patients, showing good predictive ability.
Area Of Science
- Cardiology
- Medical Informatics
- Predictive Modeling
Background
- Acute Myocardial Infarction (AMI) is a critical condition requiring timely intervention.
- Malignant Ventricular Arrhythmia (MVA) is a significant complication post-Percutaneous Coronary Intervention (PCI).
- Accurate risk prediction for MVA is crucial for patient management after PCI in AMI.
Purpose Of The Study
- To construct and validate a nomogram model for predicting MVA risk in AMI patients undergoing primary PCI.
- To identify key risk factors associated with MVA post-PCI.
- To provide a tool for better clinical decision-making and patient stratification.
Main Methods
- A retrospective cohort study involving 311 patients for training and 253 for validation.
- Multivariate logistic and stepwise regression analysis to screen risk factors.
- Nomogram construction and validation using C-index, ROC curves, decision curves, and calibration curves.
Main Results
- Urea, systolic pressure, hypertension, Killip class II-IV, and LVEF were identified as significant predictors of MVA.
- The nomogram demonstrated good predictive performance with C-indices of 0.783 (training) and 0.717 (validation).
- Validation tools confirmed the nomogram's effectiveness in forecasting MVA risk.
Conclusions
- A reliable nomogram model for predicting MVA risk after PCI in AMI patients was successfully developed.
- The model aids in predicting MVA development, enabling proactive clinical interventions.
- This tool can assist clinicians in assessing and managing MVA risk in post-PCI AMI patients.
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.